First Time Loading...

BGI Genomics Co Ltd
SZSE:300676

Watchlist Manager
BGI Genomics Co Ltd Logo
BGI Genomics Co Ltd
SZSE:300676
Watchlist
Price: 42.9 CNY 1.35%
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one BGI Genomics Co Ltd stock under the Base Case scenario is 28.85 CNY. Compared to the current market price of 42.9 CNY, BGI Genomics Co Ltd is Overvalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
28.85 CNY
Overvaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4
P/S
P/S
Price to Sales
4
vs History
68
vs Industry
70
Median 3Y
4
Median 5Y
5.3
Industry
8.3
Forward
3.8
More Details
189.3
P/E
P/E
Price to Earnings
189.3
vs History
3
vs Industry
0
Median 3Y
30.2
Median 5Y
45.7
Industry
26.8
Forward
124.9
More Details
43
P/OCF
P/OCF
Price to OCF
43
vs History
30
vs Industry
4
Median 3Y
30.5
Median 5Y
25.4
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-12.5
Industry
21.4
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
93
vs Industry
49
Median 3Y
2.5
Median 5Y
3.9
Industry
2.6
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
73
vs Industry
66
Median 3Y
3
Median 5Y
4.2
Industry
7.5
Forward
2.7
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
69
vs Industry
55
Median 3Y
5.9
Median 5Y
7.7
Industry
9.2
More Details
98
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
98
vs History
19
vs Industry
1
Median 3Y
21.8
Median 5Y
33
Industry
4.5
Forward
33.7
More Details
98
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
98
vs History
19
vs Industry
1
Median 3Y
21.8
Median 5Y
33
Industry
4.4
More Details
30.4
EV/OCF
EV/OCF
Enterprise Value to OCF
30.4
vs History
30
vs Industry
5
Median 3Y
21.3
Median 5Y
21.3
Industry
5.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-9.2
Median 5Y
-9.2
Industry
3.4
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
93
vs Industry
53
Median 3Y
3.3
Median 5Y
5.2
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
BGI Genomics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
BGI Genomics Co Ltd
SZSE:300676
17.6B CNY 4 189.3 98 98
US
Abbvie Inc
NYSE:ABBV
287.1B USD 5.3 59.6 12.9 19.7
US
Amgen Inc
NASDAQ:AMGN
161.1B USD 5.5 42.8 18.2 30
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.7B USD 10.7 29.2 23.4 24.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.9B USD 8.2 27.7 22.4 24.8
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 168.5 6.8 8.9
US
Moderna Inc
NASDAQ:MRNA
46.4B USD 9 -7.8 -8.4 -7.5
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.9B USD 3.3 27.3 14 17.5
KR
Celltrion Inc
KRX:068270
40.1T KRW 18.4 74.9 45.8 63.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.